SHIM
BSX icon

Stone House Investment Management’s Boston Scientific BSX Stock Holding History

Stone House Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$512 Buy
12
+8
+200% +$434 ﹤0.01% 1011
2026
Q1 		$251 Hold
4
– – ﹤0.01% 923
2025
Q4 		$381 Sell
4
-3
-43% -$294 ﹤0.01% 742
2025
Q3 		$683 Sell
7
-3
-30% -$311 ﹤0.01% 605
2025
Q2 		$1.07K Buy
+10
New +$1.01K ﹤0.01% 449

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stone House Investment Management's BSX Position: Q2 2026 in Review

Stone House Investment Management increased its Boston Scientific (BSX) stake by 200% in Q2 2026, buying an estimated $434 and bringing the position to 12 shares worth $512. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Stone House Investment Management first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.07K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Stone House Investment Management held 12 shares of Boston Scientific worth $512 as of Q2 2026.
  • Stone House Investment Management bought 8 Boston Scientific shares in Q2 2026, an estimated $434.
  • Boston Scientific made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #1011 holding.
  • Stone House Investment Management first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Stone House Investment Management's Boston Scientific position peaked at $1.07K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.